Your browser is no longer supported. Please, upgrade your browser.
IBB iShares Nasdaq Biotechnology daily Stock Chart
iShares Nasdaq Biotechnology
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.05%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month6.32%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter3.07%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.11 Perf Half Y1.35%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year12.00%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range240.15 - 301.61 Perf YTD9.24%
Dividend0.52 P/FCF- EPS past 5Y- ROI- 52W High-3.88% Beta-
Dividend %0.18% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.72% ATR4.20
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)60.46 Volatility1.28% 1.53%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.33 Prev Close289.32
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume1.38M Price289.90
Recom- SMA201.99% SMA504.44% SMA2004.74% Volume1,841,463 Change0.20%
Feb-24-17 04:13PM  Heres how analysts say you should trade Trumps speech to Congress at MarketWatch
12:54PM  8 Signs the Trump Trade Is Crumbling at The Wall Street Journal
Feb-21-17 05:21PM  [$$] Why Biotech Stocks Are Finally Set to Break Out at
Feb-19-17 05:15PM  Barron's Picks And Pans: General Motors, Hess, Biotechs And More
Feb-17-17 04:35PM  Stock Market Video Analysis 2/17/17
11:34AM  Biotech ETF Investors are Still on the Sidelines at Investopedia
07:37AM  Prolia Expected to Be a Significant Growth Driver for Amgen in 2017
Feb-15-17 05:19PM  Biotech boom?
04:31PM  Stock Market Video Analysis 2/15/17
02:44PM  Two Great Stock Ideas in the IBB Biotech ETF at Investopedia
09:44AM  Gilead Sciences: Its Game to Lose? at
Feb-14-17 03:07PM  The New Normal: Is The Current Bull Market Trump Resistant?
Feb-13-17 05:58PM  Final Trade: QCOM, TWTR & more
Feb-10-17 10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at
Feb-08-17 05:45PM  Gilead tanks on weak forecast
04:00PM  How To Maximize Biotech Returns Under Donald Trump at Forbes
01:28PM  Gilead: Where's the Bottom? at
Feb-07-17 07:47PM  Healthcare Stocks: The Buying Opportunity of the Year?
05:30PM  White House says Trump wants Medicare negotiation on drug...
08:15AM  3 Top Stocks to Buy for Your Kids at Motley Fool
Feb-06-17 05:01PM  Buy safety in sideways tape?
12:40PM  Priced like an automaker, sputtering Gilead shares lure value bets
Feb-03-17 03:15PM  Amgen: Who Says Biotech's Dead? at
Feb-02-17 07:20PM  Fast Money traders discuss how to trade Amgen and Amazon earnings at CNBC
05:00PM  How to trade Amgen/Amazon earnings: 5 trades
Jan-31-17 05:28PM  Making pharma great again?
03:06PM  Not all bad news with Trump pharma meeting?
01:06PM  Klain: Pharma will be net winner in exchange with Trump a...
Jan-27-17 04:30PM  What Lies Ahead for Biotech ETFs in Trump Era?
Jan-26-17 09:50AM  Why Biogen is Flying at
Jan-25-17 05:08PM  Fundstrat's Lee says to buy C.R.A.P. at Dow 20K
07:40AM  Here's How to Play the Biotech Rebound
Jan-24-17 05:05PM  Inside Amgens Oncology Segment: Multiple Investigational Therapies in 2017
04:32PM  S&P 500, Nasdaq notch new records as Dow moves closer to 20,000 at MarketWatch
02:52PM  Uncertainty on drug prices a challenge for the sector: Pr...
01:17PM  Nasdaq hits all-time high
Jan-23-17 05:18PM  Bristol Myers a takeout target?
10:31AM  Gilead Sciences: The Foggy Crystal Ball at
Jan-18-17 06:00AM  Trump Foreshadows a Bleak Outlook for Biotech at Investopedia
Jan-16-17 03:46PM  How Donald Trump's Tweets Could Make Day Trading Great Again
10:55AM  Fidelity Biotech Fund: Better than the Index? at Motley Fool
Jan-13-17 04:16PM  Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
Jan-12-17 04:35PM  Nasdaq snaps 7-day win streak as stocks cool before earning season at MarketWatch
12:01PM  Biotech ETFs Continue To Bleed at
10:51AM  ETF Investors Turn Defensive, Bid Up Bonds And Gold A Day After Trump
09:01AM  Cramer: Trump doesn't know he's central to the 'Trump ral...
08:00AM  Trending: Mexico in the Spotlight as Trump Revives 'Wall' Rhetoric
07:41AM  Thursday Hot Reads: 3 ETF Trends For 2017
Jan-11-17 07:10PM  Now that Trump has spoken, this is where traders are turning at CNBC
05:59PM  Jobless claims, Yellen speaks What you need to know in markets on Thursday
05:01PM  Is Trump the biggest risk to his own rally?
04:30PM  The Biggest Loser: Endo International Tumbles 8.6% at
04:27PM  Dow moves within 50 points of 20,000 after Trump news conference at MarketWatch
04:19PM  Trump Says Drugmakers 'Getting Away With Murder', Cites F-35, Ford, Fiat
02:36PM  Good Enough? Trump Outlines Plans to Separate from Business at Trump Tower Presser
01:47PM  Analyst: Government wouldn't want to kill goose that lays...
01:06PM  I'm a Net Seller After Trump's Talk
12:48PM  Markets wait for stimulus talk from Trump, but don't get it at CNBC
12:46PM  Dow In Driver's Seat As Merck Up; Middleby, SodaStream, Barracuda Pop
12:20PM  The market's reaction to Trump's news conference
12:12PM  Volatility Spikes as Trump Targets Biotech, Pharma Industries
11:54AM  Trump says drugmakers are 'getting away with murder,' and biotech stocks plunge at CNBC
11:00AM  With Trump In Focus, This Is The One Thing The Market Wants Most
Jan-07-17 09:42AM  Here's Why Alnylam Pharmaceuticals Plunged 59.8% in 2016 at Motley Fool
Jan-06-17 02:10PM  Rally will fade away into second half: Analyst
11:45AM  Amgen Set to Test Two Year Range Resistance (AMGN) at Investopedia
Jan-04-17 10:00AM  Gilead Sciences: With New Hire, M&A Might Be on the Way at
Jan-03-17 07:12PM  Ten Predictions for the ETF Industry in 2017
04:06PM  Trading Trump's tweets
02:22PM  13 Emerging Biotechs With Catalysts In 2017
09:15AM  The Buffett of Biotech's Portfolio at Forbes
09:15AM  Meet Miami's Renaissance Billionaire at Forbes
Dec-30-16 04:48PM  Stock Market Video Analysis 12/30/16
11:15AM  3 Sleeper Biotechs That Could Bounce Back Strong in 2017
09:32AM  'Black Cloud' Over Biotech Could Stretch Into 2017 at The Wall Street Journal
Dec-29-16 01:14PM  Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016
Dec-28-16 07:02PM  Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now
03:32PM  What to expect from biotech in 2017: Pros
10:55AM  Celgene Winding Up for 2017 Breakout (CELG, IBB) at Investopedia
Dec-27-16 02:45PM  Time for biotech to boom ... or bust?
Dec-23-16 04:03PM  Dow notches 7th straight weekly gain, longest streak in 2 years at MarketWatch
Dec-22-16 05:52PM  Biotech buying opportunity?
07:00AM  Trader's Daily Notebook: This Is Downright Sleep-Inducing
Dec-21-16 06:05PM  Revlimid Continues to Be a Key Growth Driver for Celgene in 2016
04:42PM  Stock market retreats off records as Dow falters in quest for 20,000 at MarketWatch
Dec-20-16 10:58AM  Wait, Biogen's Heading Higher? at
Dec-19-16 11:56AM  Clovis Oncology's ovarian cancer treatment gets FDA OK at MarketWatch
11:26AM  ACADIA Pharmaceuticals Inc.'s Stock Has Fallen 27% in 2016 -- Have We Hit Bottom? at Motley Fool
Dec-16-16 11:07AM  6 Best ETFs For When You're Both Bullish And Cautious About The Markets
Dec-14-16 03:54PM  Biotech ETF holds gains
12:45PM  Acorda Therapeutics CEO: With drug prices in the media, t...
10:27AM  What Might Prevent a US Recession?
06:00AM  MediciNova Added to NASDAQ Biotechnology Index GlobeNewswire
Dec-13-16 04:15PM  Stock Market Video Analysis 12/13/16
09:16AM  The Top 4 ETFs to Track the Nasdaq in 2017 at Investopedia
Dec-10-16 09:42AM  Will Trump Break With Republicans And Push Major Drug Price Reform?
Dec-09-16 07:11PM  A Record Week For Stock ETFs, But Is The Market Rally Warranted?
04:05PM  5 Stocks That Got Run Over By the Trump Train
10:52AM  S&P 500, Dow hit intraday records, on track for weekly gains at MarketWatch
Dec-08-16 05:40PM  Trump's pledge to rein in drug prices takes bite out of Seattle-area biotech stocks at
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.